Elanco Animal Health (ELAN) Research & Development (2017 - 2026)
Elanco Animal Health (ELAN) posted Research & Development of $97.0 million for Q1 2026, up 4.3% sequentially from $93.0 million in Q4 2025, and up 3.19% YoY from $94.0 million in Q1 2025.
Elanco Animal Health (ELAN) Research & Development (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Research & Development for 10 years, with the latest figure at $97.0 million in Q1 2026.
- Quarterly Research & Development rose 3.19% year-over-year to $97.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $371.0 million (up 5.7% YoY) and the FY2025 annual result came in at $368.0 million, up 6.98% from the prior year.
- Research & Development grew to $97.0 million in Q1 2026 per ELAN's latest filing, from $93.0 million in the prior quarter.
- Over five years, Research & Development peaked at $97.0 million in Q1 2026 and troughed at $78.0 million in Q3 2022.
- A 5-year average of $85.7 million and a median of $86.0 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development dropped 17.02% in 2022, then grew 14.81% in 2025.
- Over 5 years, Research & Development stood at $80.0 million in 2022, then fell by 1.25% to $79.0 million in 2023, then gained by 2.53% to $81.0 million in 2024, then advanced by 14.81% to $93.0 million in 2025, then rose by 4.3% to $97.0 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $97.0 million, $93.0 million, and $89.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn | 154.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.00 Mn |
| Mar 31, 2026 | 97.00 Mn |
| Dec 31, 2025 | 93.00 Mn |
| Sep 30, 2025 | 89.00 Mn |
| Jun 30, 2025 | 92.00 Mn |
| Mar 31, 2025 | 94.00 Mn |
| Dec 31, 2024 | 81.00 Mn |
| Sep 30, 2024 | 87.00 Mn |
| Jun 30, 2024 | 89.00 Mn |
| Mar 31, 2024 | 87.00 Mn |
| Dec 31, 2023 | 79.00 Mn |
| Sep 30, 2023 | 86.00 Mn |
| Jun 30, 2023 | 81.00 Mn |
| Mar 31, 2023 | 81.00 Mn |
| Dec 31, 2022 | 80.00 Mn |
| Sep 30, 2022 | 78.00 Mn |
| Jun 30, 2022 | 82.00 Mn |
| Mar 31, 2022 | 81.00 Mn |
| Dec 31, 2021 | 92.00 Mn |
| Sep 30, 2021 | 94.00 Mn |